263 related articles for article (PubMed ID: 11389524)
21. New developments in the diagnosis and treatment of infections in lung transplant recipients.
Zaas AK; Alexander BD
Respir Care Clin N Am; 2004 Dec; 10(4):531-47. PubMed ID: 15585181
[TBL] [Abstract][Full Text] [Related]
22. Lung transplantation for cystic fibrosis: 6-year follow-up.
Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
[TBL] [Abstract][Full Text] [Related]
23. Late infection in cardiac allograft recipients: profiles, incidence, and outcome.
Hosenpud JD; Hershberger RE; Pantely GA; Norman DJ; Hovaguimian H; Cobanoglu A; Starr A
J Heart Lung Transplant; 1991; 10(3):380-6. PubMed ID: 1854765
[TBL] [Abstract][Full Text] [Related]
24. Fungal infections after lung transplantation.
Solé A; Salavert M
Transplant Rev (Orlando); 2008 Apr; 22(2):89-104. PubMed ID: 18631862
[TBL] [Abstract][Full Text] [Related]
25. Infectious complications in heart-lung transplantation. Analysis of 200 episodes.
Kramer MR; Marshall SE; Starnes VA; Gamberg P; Amitai Z; Theodore J
Arch Intern Med; 1993 Sep; 153(17):2010-6. PubMed ID: 8357286
[TBL] [Abstract][Full Text] [Related]
26. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation.
Ruttmann E; Geltner C; Bucher B; Ulmer H; Höfer D; Hangler HB; Semsroth S; Margreiter R; Laufer G; Müller LC
Transplantation; 2006 May; 81(10):1415-20. PubMed ID: 16732179
[TBL] [Abstract][Full Text] [Related]
27. [Rapid diagnosis of infectious complications after transplantation].
Ishii KK
Rinsho Byori; 2002 Nov; 50(11):1055-60. PubMed ID: 12491602
[TBL] [Abstract][Full Text] [Related]
28. Extended ganciclovir prophylaxis in lung transplantation.
Perreas KG; McNeil K; Charman S; Sharples LD; Wreghitt T; Wallwork J
J Heart Lung Transplant; 2005 May; 24(5):583-7. PubMed ID: 15896756
[TBL] [Abstract][Full Text] [Related]
29. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
Shah T; Lai WK; Mutimer D
Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
[TBL] [Abstract][Full Text] [Related]
30. Is gammaglobulin anti-CMV warranted in lung transplantation?
García-Gallo CL; Gil PU; Laporta R; Carreño MC; de Pablo A; Ferreiro MJ
Transplant Proc; 2005 Nov; 37(9):4043-5. PubMed ID: 16386622
[TBL] [Abstract][Full Text] [Related]
31. Special considerations regarding CMV in lung transplantation.
Avery RK
Transpl Infect Dis; 1999; 1 Suppl 1():13-8. PubMed ID: 11565581
[TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
34. Infectious complications after kidney transplantation: a single-center experience.
Pourmand G; Salem S; Mehrsai A; Taherimahmoudi M; Ebrahimi R; Pourmand MR
Transpl Infect Dis; 2007 Dec; 9(4):302-9. PubMed ID: 17511823
[TBL] [Abstract][Full Text] [Related]
35. Viral infection following kidney transplantation: long-term follow-up in a single center.
Hwang EA; Kang MJ; Han SY; Park SB; Kim HC
Transplant Proc; 2004 Sep; 36(7):2118-9. PubMed ID: 15518767
[TBL] [Abstract][Full Text] [Related]
36. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
37. Late cytomegalovirus disease following liver transplantation.
Shibolet O; Ilan Y; Kalish Y; Safadi R; Ashur Y; Eid A; Shouval D; Wolf D
Transpl Int; 2003 Dec; 16(12):861-5. PubMed ID: 12904846
[TBL] [Abstract][Full Text] [Related]
38. Changing impact of cytomegalovirus in liver transplantation -- a single centre experience of more than 1000 transplantations without ganciclovir prophylaxis.
Seehofer D; Rayes N; Neumann UP; Meisel H; Oettle H; Nüssler NC; Jonas S; Langrehr JM; Neuhaus P
Transpl Int; 2005 Aug; 18(8):941-8. PubMed ID: 16008744
[TBL] [Abstract][Full Text] [Related]
39. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
40. Trends in invasive disease due to Candida species following heart and lung transplantation.
Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
